CRYAB and neoplasm: A recent observation from analysis of clinicopathological data of OvCa patients (n=103) has shown that increased expression of HSPB5 alone/with the co-expression with p53 results in the poorer outcome and correlates with the tumor size, TNM staging, and decreased survival (Tan et al., 2019[57]).